Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 14 de 14
Filter
Add more filters










Publication year range
3.
Neurochem Res ; 34(12): 2122-32, 2009 Dec.
Article in English | MEDLINE | ID: mdl-19488852

ABSTRACT

Markers of oxidative stress were measured in blood samples of 338 subjects (965 observations): Alzheimer's, vascular dementia, diabetes (type II) superimposed to dementias, Parkinson's disease and controls. Patients showed increased thiobarbituric acid reactive substances (+21%; P < 0.05), copper-zinc superoxide dismutase (+64%; P < 0.001) and decreased antioxidant capacity (-28%; P < 0.001); pairs of variables resulted linearly related across groups (P < 0.001). Catalase and glutathione peroxidase, involved in discrimination between diseases, resulted non-significant. When diabetes is superimposed with dementias, changes resulted less marked but significant. Also, superoxide dismutase resulted not linearly correlated with any other variable or age-related (pure Alzheimer's peaks at 70 years, P < 0.001). Systemic oxidative stress was significantly associated (P << 0.001) with all diseases indicating a disbalance in peripheral/adaptive responses to oxidative disorders through different free radical metabolic pathways. While other changes - methionine cycle, insulin correlation - are also associated with dementias, the responses presented here show a simple linear relation between prooxidants and antioxidant defenses.


Subject(s)
Alzheimer Disease/metabolism , Dementia, Vascular/metabolism , Oxidative Stress/physiology , Parkinson Disease/metabolism , Aged , Antioxidants/metabolism , Diabetes Mellitus, Type 2/metabolism , Female , Free Radicals , Humans , Male , Middle Aged , Superoxide Dismutase/blood , Thiobarbituric Acid Reactive Substances/analysis
4.
Vertex ; 19 Suppl: 7-14, 2008.
Article in Spanish | MEDLINE | ID: mdl-18392209

ABSTRACT

Dementia is a chronic progressive mental disorder, which adversely affects different domains as memory, thinking, comprehension, judgment, orientation, calculation or language. People with dementia eventually lose the ability to carry out routine daily activities such as dressing, toileting, traveling and handling money. Memory impairment and dementia are commonly seen by physicians in multiple disciplines including primary care, geriatrics, neurology, and psychiatry. We discuss the pros and cons of brief cognitive tests such as the Mini-mental State Examination (MMSE) and test for executive functions to detect cognitive impairment in community patients. Diagnosis must meet standard diagnostic criteria, including tests of cognitive, global and behavioral functioning and activities of daily living. Preliminary diagnosis often takes place in primary care, usually followed by specialist assessment. In this paper we discuss operational criteria for diagnosis in primary care. An algorithm for practical physicians is proposed.


Subject(s)
Algorithms , Dementia/diagnosis , Primary Health Care , Humans , Primary Health Care/methods
5.
Headache ; 47(8): 1213-5, 2007 Sep.
Article in English | MEDLINE | ID: mdl-17883530

ABSTRACT

Temporal arteritis is a form of systemic vasculitis that involves branches of the carotid artery. Clinical features are headache, visual loss, ophthalmoplegia, jaw claudication, temporal headache, with tenderness and thickening on the affected temporal artery. We present 3 cases of tongue necrosis due to this granulomatous arteritis. Ischemic necrosis of the tongue is unusual and appears to be an association between its occurrence and high dose steroid tapering.


Subject(s)
Giant Cell Arteritis/pathology , Giant Cell Arteritis/physiopathology , Tongue/pathology , Aged , Female , Humans , Necrosis/chemically induced , Steroids/adverse effects , Tongue/drug effects
6.
Clin Chim Acta ; 359(1-2): 163-70, 2005 Sep.
Article in English | MEDLINE | ID: mdl-15935339

ABSTRACT

BACKGROUND: Increased concentration of plasmatic homocysteine (tHcy) and decreased vitamin B 12 (B12) and folate (FOL) are associated with Alzheimer's (AD) and vascular (VaD) dementias, with type II diabetes mellitus (DM), and reported as risk factors of these diseases. METHODS: The sample (n=122; males=60; mean age=73+/-7 years) comprised AD and VaD patients without DM, with a concomitant DM (AD+DM, VaD+DM), DM alone and controls (CTR), resulting in 6 groups. tHcy, B12 and FOL were determined in duplicate. RESULTS: The one-way ANOVA yielded significant differences between groups for all variables: tHcy p<10(-12); B12 p<10(-3); FOL p<10(-4). Significance for comparisons between groups was set at alpha=0.05, using the Bonferroni's statistic. The comparisons: DM vs. CTR, AD+DM vs. AD, VaD+DM vs. VaD, and DM demented vs. DM non-demented resulted significant for all variables, except for B12 in 2 comparisons. CONCLUSIONS: In demented and control subjects, tHcy and FOL exhibit extreme differences, not so marked between DM and controls. Demented patients with concomitant diabetes are closer to controls than their non-diabetic counterparts. Diabetes affects tHcy and FOL values, which are changed with opposite sign to non-demented. These results suggests a paradoxical phenomenon when diabetes is superimposed to dementias.


Subject(s)
Alzheimer Disease/blood , Dementia, Vascular/blood , Diabetes Mellitus, Type 2/blood , Folic Acid/blood , Homocysteine/blood , Vitamin B 12/blood , Aged , Alzheimer Disease/complications , Analysis of Variance , Dementia, Vascular/complications , Diabetes Mellitus, Type 2/complications , Female , Humans , Male
7.
J Neurol Sci ; 218(1-2): 17-24, 2004 Mar 15.
Article in English | MEDLINE | ID: mdl-14759628

ABSTRACT

Oxidative stress is associated with Alzheimer's (DAT) and vascular (VD) dementias, as well as Type II diabetes mellitus (DIAB) and affected by hypoglycemic therapy. The population (n = 122; males = 60; mean age = 72.57 +/- 7.06) consisted of controls (CTR), DAT and VD patients, with (DAT + DIAB, VD + DIAB) and without concomitant DIAB, resulting in six groups where the antioxidant profile was determined: copper-zinc superoxide dismutase (SOD), thiobarbituric acid reactive substances (TBARS), and total antioxidant capacity (TRAP). The results were analyzed using a two-way ANOVA design and Bonferroni statistic. The ANOVAs yielded significant differences between groups for all components of the profile: SOD, p = 0.00000006; TBARS, p = 0.0000012; TRAP, p = 0.0000003. The significance level for comparisons between groups was set at alpha = 0.05. The comparisons DIAB vs. CTR, DAT+DIAB vs. DAT, and DIAB demented vs. DIAB non-demented resulted significant for all variables. VD + DIAB vs. VD resulted significant for all variables except TRAP. The antioxidant profiles of DIAB and CTR are different. The differences cannot be directly related with what is observed in dementias. The differences in profiles of demented and non-demented are somewhat hidden when demented patients are affected by a concomitant DIAB condition and/or hypoglycemic treatment, thus conditioning the diagnostic value for dementias of the profiles.


Subject(s)
Alzheimer Disease/metabolism , Antioxidants/metabolism , Dementia, Vascular/metabolism , Diabetes Mellitus, Type 2/metabolism , Oxidative Stress , Aged , Aged, 80 and over , Alzheimer Disease/blood , Alzheimer Disease/complications , Analysis of Variance , Dementia, Vascular/blood , Dementia, Vascular/complications , Diabetes Mellitus, Type 2/blood , Diabetes Mellitus, Type 2/complications , Female , Humans , Male , Superoxide Dismutase/blood , Thiobarbituric Acid Reactive Substances/metabolism
8.
J Neurol Sci ; 203-204: 67-71, 2002 Nov 15.
Article in English | MEDLINE | ID: mdl-12417359

ABSTRACT

Stroke is the main manifestation of cerebrovascular disease (CVD). Few studies report the insidious and progressive development of CVD. The aim of this study was the characterization of a CVD form without stroke in association with vascular subtypes and risk factors (VRF). From 105 CVD patients, 65 had stroke (62%), 13 of them had more than one stroke (20%), and 40 patients had a chronic progressive form (CPF) (38%). Mean evolution times up to maximum neurological deficiency were 1.57+/-0.94 and 344.25+/-210.96 days, respectively. Group results significantly associated with VRFs: hypertension (p=0.0046), hyperlipemia (p=0.0046) and atrial fibrillation (p=0.0173); with clinical manifestations: aphasia (p=0.0018), pyramidal syndrome (p=0.0000001) and small vessel disease (SVD) (p=0.0000001); and with MRI: bilateral infarctions (p=0.00009) and incomplete white matter lesions (IWMLs) (p=0.0061). Within the CPF group, dysarthria and complete infarctions were associated (p=0.00036). Most neurological disorders associated with CVD are related to CPF. The significant correlations of SVD, bilateral infarcts, IWMLs, dysarthria, several VRFs and the strong difference in evolution time up to maximum neurological deficiency values characterize CPF as a separate entity within CVD.


Subject(s)
Cerebrovascular Disorders/pathology , Cerebrovascular Disorders/psychology , Stroke/pathology , Stroke/psychology , Aged , Argentina , Chronic Disease , Disease Progression , Female , Humans , Magnetic Resonance Imaging , Male , Neuropsychological Tests , Prospective Studies , Risk Factors , Stroke/etiology
SELECTION OF CITATIONS
SEARCH DETAIL
...